Recruiting
Phase 1

Sitagliptin & Pembrolizumab

Sponsor:

Fernando Maciel Barbosa

Code:

NCT07634380

Conditions

Advanced Renal Cell Carcinoma

Advanced Melanoma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Sitagliptin

Pembrolizumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-25. This information was provided to ClinicalTrials.gov by Fernando Maciel Barbosa on 2026-07-30.